I
145.21
-6.23 (-4.11%)
| Penutupan Terdahulu | 151.44 |
| Buka | 143.00 |
| Jumlah Dagangan | 4,000,216 |
| Purata Dagangan (3B) | 1,291,324 |
| Modal Pasaran | 11,735,989,248 |
| Harga / Pendapatan (P/E TTM) | 15.82 |
| Harga / Pendapatan (P/E Ke hadapan) | 10.27 |
| Harga / Jualan (P/S) | 1.46 |
| Harga / Buku (P/B) | 1.24 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Jul 2025 - 28 Jul 2025 |
| Margin Keuntungan | 9.56% |
| Margin Operasi (TTM) | 17.21% |
| EPS Cair (TTM) | 9.53 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 20.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 37.83% |
| Nisbah Semasa (MRQ) | 1.26 |
| Aliran Tunai Operasi (OCF TTM) | 1.29 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.09 B |
| Pulangan Atas Aset (ROA TTM) | 4.50% |
| Pulangan Atas Ekuiti (ROE TTM) | 8.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menurun | Menurun |
| Diagnostics & Research (Global) | Menurun | Menurun | |
| Stok | ICON plc | Menurun | Menurun |
AISkor Stockmoo
0.3
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | 0.0 |
| Purata | 0.25 |
|
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 0.61% |
| % Dimiliki oleh Institusi | 97.81% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bluespruce Investments, Lp | 31 Dec 2024 | 1,223,117 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 215.00 (Citigroup, 48.06%) | Beli |
| Median | 160.00 (10.19%) | |
| Rendah | 150.00 (JP Morgan, 3.30%) | Pegang |
| Purata | 172.25 (18.62%) | |
| Jumlah | 3 Beli, 5 Pegang | |
| Harga Purata @ Panggilan | 128.14 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Mizuho | 15 May 2025 | 173.00 (19.14%) | Beli | 0.000 |
| 09 Apr 2025 | 200.00 (37.73%) | Beli | 155.49 | |
| Baird | 02 May 2025 | 160.00 (10.19%) | Pegang | 145.21 |
| 04 Mar 2025 | 203.00 (39.80%) | Pegang | 183.62 | |
| Barclays | 02 May 2025 | 155.00 (6.74%) | Pegang | 145.21 |
| 10 Apr 2025 | 165.00 (13.63%) | Pegang | 142.64 | |
| Goldman Sachs | 02 May 2025 | 160.00 (10.19%) | Pegang | 145.21 |
| 21 Mar 2025 | 200.00 (37.73%) | Pegang | 184.87 | |
| JP Morgan | 29 Apr 2025 | 150.00 (3.30%) | Pegang | 149.31 |
| TD Cowen | 14 Apr 2025 | 157.00 (8.12%) | Pegang | 146.74 |
| Truist Securities | 10 Apr 2025 | 208.00 (43.24%) | Beli | 142.64 |
| Citigroup | 07 Apr 2025 | 215.00 (48.06%) | Beli | 150.83 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |